¥5,885.00
0.43%
Tokyo, Sep 24, 03:30 pm JST.
ISIN
JP3301100008
Symbol
4967

Kobayashi Pharmaceutical Stock price

¥6,885.00
+1,205.00 21.21% 1M
+1,119.00 19.41% 6M
+1,457.00 26.84% YTD
+1,488.00 27.57% 1Y
-16.00 0.23% 3Y
-2,025.00 22.73% 5Y
+1,625.00 30.89% 10Y
+4,720.00 218.01% 20Y
Tokyo, Closing price Fri, Sep 25 2026
+1,000.00 16.99%
Compare with Peer Group
ISIN
JP3301100008
Symbol
4967

Is Kobayashi Pharmaceutical a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 9,127 stocks worldwide.

Key metrics

Basic
Market capitalization
¥434.6b
Enterprise Value
¥370.3b
Net debt
-
Cash
-
Shares outstanding
-
Valuation (TTM | estimate)
P/E
269.2
P/S
2.6 | 2.5
EV/Sales
2.2 | 2.1
EV/FCF
-
P/B
2.1
Dividends
DPS
¥106.00
Yield 1Y | 5Y
1.8% | 1.5%
Growth 1Y | 5Y
1.9% | 5.0%
Payout 1Y | 3Y
211.5% | 67.8%
Increased
9 Years
Financials (TTM | estimate)
Revenue
¥167.5b | ¥173.9b
EBITDA
-
EBIT
¥10.4b
Net Income
¥1.6b
Free Cash Flow
-
Growth (TTM | estimate)
Revenue
3.7% | 4.9%
EBITDA
-
EBIT
-52.6%
Net Income
-86.2%
Free Cash Flow
-
Margin
Gross
50.7%
EBITDA
-
EBIT
6.2%
Net
1.0%
Free Cash Flow
-
Financial Health
Equity Ratio
76.6%
Return on Equity
1.7%
ROCE
4.9%
ROIC
6.5%
Debt/Equity
-
More
EPS
¥21.9
FCF per Share
-
Short interest
-
Employees
4k
Rev per Employee
¥44.4m

Kobayashi Pharmaceutical Stock Analysis

Unlock Scores for Free

Analyst Opinions

14 Analysts have issued a Kobayashi Pharmaceutical forecast:

2x Buy
14%
6x Hold
43%
6x Sell
43%

Analyst Opinions

14 Analysts have issued a Kobayashi Pharmaceutical forecast:

Buy
14%
Hold
43%
Sell
43%

Financial data from Kobayashi Pharmaceutical

Jun '26
+/-
%
167,473 167,473
4% 4%
100%
- Direct Costs 82,575 82,575
5% 5%
49%
84,898 84,898
2% 2%
51%
- Selling and Administrative Expenses 74,460 74,460
22% 22%
44%
- Research and Development Expense - -
-
-
- -
-
-
- Depreciation and Amortization - -
-
-
EBIT (Operating Income) EBIT 10,437 10,437
53% 53%
6%
Net Profit 1,625 1,625
86% 86%
1%

In millions JPY.

Don't miss a Thing! We will send you all news about Kobayashi Pharmaceutical directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Kobayashi Pharmaceutical Co., Ltd. engages in the manufacture and sale of over-the-counter (OTC) pharmaceuticals, quasi-drugs, air fresheners, and sanitary products. It operates through the following segments: Domestic, International, Mail Order, and Others. The Domestic segment manufactures and sells health care products, daily necessities, skin care products, and body warmers in Japan. The International segment sells beauty and health care products overseas. The Mail Order segment offers nutritional supplements and skin care products online. The Others segment includes transportation, synthetic resin container, advertising planning and production, insurance agency, and real estate businesses. The company was founded by Chubei Kobayashi in February 1886 and is headquartered in Osaka, Japan.

Head office Japan
CEO Norikaz Toyoda
Employees 3,731
Founded 1886
Website www.kobayashi.co.jp

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today